home / stock / tern / tern quote
Last: | $5.86 |
---|---|
Change Percent: | 5.12% |
Open: | $5.74 |
Close: | $5.86 |
High: | $5.96 |
Low: | $5.435 |
Volume: | 1,945,722 |
Last Trade Date Time: | 05/09/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.86 | $5.74 | $5.86 | $5.96 | $5.435 | 1,945,722 | 05-09-2024 |
$6.05 | $5.7 | $6.05 | $6.12 | $5.59 | 747,999 | 05-08-2024 |
$5.76 | $5.83 | $5.76 | $5.95 | $5.6268 | 803,181 | 05-07-2024 |
$5.79 | $5.47 | $5.79 | $5.81 | $5.47 | 476,742 | 05-06-2024 |
$5.44 | $5.39 | $5.44 | $5.57 | $5.21 | 564,419 | 05-03-2024 |
$5.29 | $5.18 | $5.29 | $5.34 | $5.08 | 503,294 | 05-02-2024 |
$5.08 | $5.04 | $5.08 | $5.39 | $4.91 | 959,782 | 05-01-2024 |
$5.05 | $5.2 | $5.05 | $5.2341 | $4.895 | 1,249,905 | 04-30-2024 |
$5.1 | $4.93 | $5.1 | $5.23 | $4.93 | 492,434 | 04-29-2024 |
$4.91 | $4.68 | $4.91 | $4.93 | $4.62 | 497,177 | 04-26-2024 |
$4.64 | $4.65 | $4.64 | $4.72 | $4.42 | 597,913 | 04-25-2024 |
$4.75 | $4.74 | $4.75 | $4.845 | $4.64 | 409,741 | 04-24-2024 |
$4.69 | $4.82 | $4.69 | $5.0289 | $4.67 | 544,086 | 04-23-2024 |
$4.82 | $4.57 | $4.82 | $4.85 | $4.4772 | 535,597 | 04-22-2024 |
$4.56 | $4.59 | $4.56 | $4.6499 | $4.32 | 866,472 | 04-19-2024 |
$4.59 | $4.49 | $4.59 | $4.65 | $4.3738 | 694,069 | 04-18-2024 |
$4.54 | $4.72 | $4.54 | $4.8 | $4.5 | 762,894 | 04-17-2024 |
$4.67 | $4.96 | $4.67 | $4.985 | $4.66 | 656,228 | 04-16-2024 |
$5.06 | $5.05 | $5.06 | $5.16 | $4.82 | 695,703 | 04-15-2024 |
$5.14 | $5.22 | $5.14 | $5.2896 | $5.01 | 737,584 | 04-12-2024 |
News, Short Squeeze, Breakout and More Instantly...
Terns Pharmaceuticals Inc. Company Name:
TERN Stock Symbol:
NASDAQ Market:
FOSTER CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including on...
FOSTER CITY, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage bio...
FOSTER CITY, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including on...